Recent Quotes

My Watchlist

Indicators

Elicio Therapeutics Inc (NQ: ELTX )

4.840 +0.230 (+4.99%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	13,701
Open	4.650
Bid (Size)	3.500 (1)
Ask (Size)	5.540 (3)
Prev. Close	4.610
Today's Range	4.650 - 4.940
52wk Range	2.960 - 11.45
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit

October 31, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Elicio Therapeutics Reports Inducement Grants

October 16, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Performance

YTD	-18.38%	-18.38%
1 Month	+5.68%	+5.68%
3 Month	+8.76%	+8.76%
6 Month	-46.10%	-46.10%
1 Year	-31.83%	-31.83%

More News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

October 01, 2024

Via Benzinga

Elicio Therapeutics Reports Inducement Grants

September 17, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines

September 13, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

August 28, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

ELTX Stock Earnings: Elicio Therapeutics Beats EPS for Q2 2024

August 13, 2024

Via InvestorPlace

Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

August 13, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note

August 12, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday?

June 28, 2024

Via Benzinga

Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering

June 28, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today?

June 28, 2024

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

June 28, 2024

Via InvestorPlace

Elicio Therapeutics Announces Proposed Public Offering

June 27, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P

June 27, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors

June 10, 2024

Via News Direct

12 Health Care Stocks Moving In Thursday's Intraday Session

May 16, 2024

Via Benzinga

ELTX Stock Earnings: Elicio Therapeutics Beats EPS for Q1 2024

May 15, 2024

Via InvestorPlace

Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry

April 11, 2024

Via News Direct

12 Health Care Stocks Moving In Friday's After-Market Session

April 05, 2024

Via Benzinga

Unlocking the Power of Immunotherapy: Elicio Therapeutics’ (NASDAQ: ELTX) Novel AMP Platform

April 05, 2024

Via News Direct

ELTX Stock Earnings: Elicio Therapeutics Misses EPS for Q4 2023

April 02, 2024

Via InvestorPlace

Benzinga's 2024 Virtual Healthcare: What's Next In Health?

March 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session

March 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session

March 18, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.